识别与道相关的目标基因,以构建胰岛素瘤的诊断模型
Shuangyang Mo1,2, Yingwei Wang1, Wenhong Wu1
1Gastroenterology Department, Liuzhou People's Hospital Affiliated to Guangxi Medical University, Liuzhou, China.
Frontiers in genetics
|September 29, 2023
概括
研究人员确定了三个关键的离子通道相关基因,并开发了胰岛素瘤的诊断模型,为早期检测和了解这种常见的胰腺神经内分泌瘤提供了一种新方法.
科学领域:
- 生物医学研究的研究.
- 基因组学就是基因组学.
- 在瘤学瘤学.
背景情况:
- 胰岛素瘤是最常见的功能性胰腺神经内分泌瘤 (PNET),其特征是异常的胰岛素过分分泌.
- 胰岛素瘤的确切原因尚不清楚,需要新的诊断策略.
- 这项研究研究了与离子通道相关的基因,以阐明分子机制,并建立胰岛素瘤的遗传诊断模型.
研究的目的:
- 为了确定关键的离子通道相关基因,涉及胰岛素瘤的发病.
- 使用机器学习开发和验证胰岛素瘤的预测诊断模型.
- 探索与已识别的基因相关的分子通路和免疫微环境.
主要方法:
- 从胰岛素瘤,非功能性PNET和正常小岛样本中分析mRNA表达特征.
- 使用生物信息学和机器学习 (LASSO,SVM-RFE) 识别差异表达的离子通道相关基因 (DEICRGs).
- 使用接收器运行特征 (ROC) 曲线构建和验证名录诊断模型,以及免疫透和基因组丰富分析 (GSEA,GSVA).
主要成果:
- 确定了29个DEICRG,富含与离子运输,平衡,胰腺分泌和溶酶体相关的途径.
- 三个目标基因 (MCOLN1,ATP6V0E1,ATP4A) 通过蛋白质-蛋白质相互作用 (PPI) 和机器学习被精确地确定.
- 基于这些基因的诊断模型显示出高预测精度 (AUC = 0.801),与胰岛素分泌和 lysosome 功能正相关,与TGF-β信号负相关.
结论:
- 三种特定的离子通道相关基因已被确定为胰岛素瘤的潜在生物标志物.
- 利用这些基因的新型,高效的诊断模型为胰岛素瘤诊断提供了一个有前途的工具.
- 对这些基因和通路的进一步研究可能会揭示胰岛素瘤的新治疗点.
相关概念视频
Insulin: The Receptor and Signaling Pathways
1.3K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.3K
Insulin Secretory Vesicles
5.0K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.0K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


